Cite
Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation.
MLA
Wei-Chih Lien, et al. “Therapeutic Potential of Nanoceria Pretreatment in Preventing the Development of Urological Chronic Pelvic Pain Syndrome: Immunomodulation via Reactive Oxygen Species Scavenging and SerpinB2 Downregulation.” Bioengineering & Translational Medicine, vol. 8, no. 1, Jan. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1002/btm2.10346.
APA
Wei-Chih Lien, Xin-Ran Zhou, Ya-Jyun Liang, Congo Tak-Shing Ching, Chia-Yih Wang, Fu-I Lu, Huei-Cih Chang, Feng-Huei Lin, & Wang, H.-M. D. (2023). Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation. Bioengineering & Translational Medicine, 8(1), 1–13. https://doi.org/10.1002/btm2.10346
Chicago
Wei-Chih Lien, Xin-Ran Zhou, Ya-Jyun Liang, Congo Tak-Shing Ching, Chia-Yih Wang, Fu-I Lu, Huei-Cih Chang, Feng-Huei Lin, and Hui-Min David Wang. 2023. “Therapeutic Potential of Nanoceria Pretreatment in Preventing the Development of Urological Chronic Pelvic Pain Syndrome: Immunomodulation via Reactive Oxygen Species Scavenging and SerpinB2 Downregulation.” Bioengineering & Translational Medicine 8 (1): 1–13. doi:10.1002/btm2.10346.